LAL-AR-N-2005:Study Treatment for Children High Risk Acute Lymphoblastic Leukemia
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The study objective is to improve the global results obtained with LAL-AR-93 study, reaching
an event free survival between 60-70%.
Identify patients with bad prognosis, with minimal residual disease,who can benefit of
allogenic bone marrow transplantation